BGLAF
Price
$10.42
Change
+$0.84 (+8.77%)
Updated
Jul 29 closing price
Capitalization
1.01B
SHPH
Price
$3.32
Change
-$0.18 (-5.14%)
Updated
Aug 15 closing price
Capitalization
3.55M
Interact to see
Advertisement

BGLAF vs SHPH

Header iconBGLAF vs SHPH Comparison
Open Charts BGLAF vs SHPHBanner chart's image
Biogaia AB
Price$10.42
Change+$0.84 (+8.77%)
Volume$1K
Capitalization1.01B
Shuttle Pharmaceuticals Holdings
Price$3.32
Change-$0.18 (-5.14%)
Volume$49.29K
Capitalization3.55M
BGLAF vs SHPH Comparison Chart in %
Loading...
BGLAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGLAF vs. SHPH commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGLAF is a Hold and SHPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (BGLAF: $10.42 vs. SHPH: $3.32)
Brand notoriety: BGLAF and SHPH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BGLAF: 47% vs. SHPH: 31%
Market capitalization -- BGLAF: $1.01B vs. SHPH: $3.55M
BGLAF [@Pharmaceuticals: Generic] is valued at $1.01B. SHPH’s [@Pharmaceuticals: Generic] market capitalization is $3.55M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGLAF’s FA Score shows that 1 FA rating(s) are green whileSHPH’s FA Score has 0 green FA rating(s).

  • BGLAF’s FA Score: 1 green, 4 red.
  • SHPH’s FA Score: 0 green, 5 red.
According to our system of comparison, BGLAF is a better buy in the long-term than SHPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BGLAF’s TA Score shows that 1 TA indicator(s) are bullish while SHPH’s TA Score has 2 bullish TA indicator(s).

  • BGLAF’s TA Score: 1 bullish, 1 bearish.
  • SHPH’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BGLAF is a better buy in the short-term than SHPH.

Price Growth

BGLAF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SHPH (@Pharmaceuticals: Generic) price change was -2.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGLAF($1.01B) has a higher market cap than SHPH($3.56M). BGLAF YTD gains are higher at: 8.768 vs. SHPH (-84.540). BGLAF has higher annual earnings (EBITDA): 393M vs. SHPH (-9.59M). BGLAF has more cash in the bank: 622M vs. SHPH (4.51M). BGLAF has higher revenues than SHPH: BGLAF (1.44B) vs SHPH (0).
BGLAFSHPHBGLAF / SHPH
Capitalization1.01B3.56M28,354%
EBITDA393M-9.59M-4,099%
Gain YTD8.768-84.540-10%
P/E Ratio35.13N/A-
Revenue1.44B0-
Total Cash622M4.51M13,785%
Total DebtN/A1.1M-
TECHNICAL ANALYSIS
Technical Analysis
BGLAFSHPH
RSI
ODDS (%)
Bearish Trend 2 days ago
50%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
23%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
22%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BGLAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEN10.570.02
+0.19%
Wendy's Company
LOOP1.55N/A
N/A
Loop Industries
BWB15.75-0.21
-1.32%
Bridgewater Bancshares
ENTG77.12-1.75
-2.22%
Entegris
RDHL1.36-0.05
-3.55%
Redhill Biopharma Ltd

BGLAF and

Correlation & Price change

A.I.dvisor tells us that BGLAF and SNOA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and SNOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
SNOA - BGLAF
30%
Poorly correlated
+1.52%
CTTH - BGLAF
28%
Poorly correlated
-2.61%
SHPH - BGLAF
8%
Poorly correlated
-5.14%
SDZXF - BGLAF
5%
Poorly correlated
+2.12%
TSNDF - BGLAF
3%
Poorly correlated
+1.10%
More

SHPH and

Correlation & Price change

A.I.dvisor tells us that SHPH and LFCR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPH and LFCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPH
1D Price
Change %
SHPH100%
-5.14%
LFCR - SHPH
31%
Poorly correlated
-0.67%
PLSH - SHPH
25%
Poorly correlated
N/A
YCBD - SHPH
22%
Poorly correlated
-10.98%
ESALF - SHPH
22%
Poorly correlated
+0.32%
TKNO - SHPH
21%
Poorly correlated
-2.29%
More